調査レポート | • レポートコード：QYR2104Z1227 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、中枢神経系（CNS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経血管、外傷、メンタルヘルス、変性疾患、感染症、癌）、用途別市場規模（臨床用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・中枢神経系（CNS）治療の市場動向 ・企業の競争状況、市場シェア ・中枢神経系（CNS）治療の種類別市場規模（神経血管、外傷、メンタルヘルス、変性疾患、感染症、癌） ・中枢神経系（CNS）治療の用途別市場規模（臨床用、その他） ・中枢神経系（CNS）治療の北米市場規模2016-2027（アメリカ、カナダ） ・中枢神経系（CNS）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・中枢神経系（CNS）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・中枢神経系（CNS）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・中枢神経系（CNS）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Biogen、Johnson & Johnson、Eli Lilly、Otsuka America Pharmaceutical、Merck、Astrazeneca、Novartis、Teva Pharmaceutical Industries、Takeda） ・結論 |
A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.
Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market.
Market Analysis and Insights: Global Central Nervous System (CNS) Therapeutic Market
The global Central Nervous System (CNS) Therapeutic market size is projected to reach US$ 93600 million by 2026, from US$ 74150 million in 2019, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Central Nervous System (CNS) Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Central Nervous System (CNS) Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Central Nervous System (CNS) Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Central Nervous System (CNS) Therapeutic market.
Global Central Nervous System (CNS) Therapeutic Scope and Market Size
Central Nervous System (CNS) Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Segment by Application
Clinical Application
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neurovascular
1.2.3 Trauma
1.2.4 Mental Health
1.2.5 Degenerative Disorder
1.2.6 Infections
1.2.7 Cancer
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Application
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2016-2027)
2.2 Central Nervous System (CNS) Therapeutic Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Central Nervous System (CNS) Therapeutic Industry Dynamic
2.3.1 Central Nervous System (CNS) Therapeutic Market Trends
2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2020
3.5 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2022-2027)
5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2016-2027)
6.2 North America Central Nervous System (CNS) Therapeutic Market Size by Type
6.2.1 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2027)
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Application
6.3.1 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2027)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country
6.4.1 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2016-2027)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Type
7.2.1 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2027)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Application
7.3.1 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2027)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country
7.4.1 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type
8.2.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application
8.3.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region
8.4.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2016-2027)
9.2 Latin America Central Nervous System (CNS) Therapeutic Market Size by Type
9.2.1 Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Application
9.3.1 Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country
9.4.1 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type
10.2.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application
10.3.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country
10.4.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Details
11.5.2 Otsuka America Pharmaceutical Business Overview
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.5.5 Otsuka America Pharmaceutical Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Company Details
11.7.2 Astrazeneca Business Overview
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.7.5 Astrazeneca Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021)
11.10.5 Takeda Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neurovascular
Table 3. Key Players of Trauma
Table 4. Key Players of Mental Health
Table 5. Key Players of Degenerative Disorder
Table 6. Key Players of Infections
Table 7. Key Players of Cancer
Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2016-2021)
Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2022-2027)
Table 14. Central Nervous System (CNS) Therapeutic Market Trends
Table 15. Central Nervous System (CNS) Therapeutic Market Drivers
Table 16. Central Nervous System (CNS) Therapeutic Market Challenges
Table 17. Central Nervous System (CNS) Therapeutic Market Restraints
Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2016-2021)
Table 20. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2020)
Table 21. Ranking of Global Top Central Nervous System (CNS) Therapeutic Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
Table 25. Date of Enter into Central Nervous System (CNS) Therapeutic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2016-2021)
Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Central Nervous System (CNS) Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2016-2021)
Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Central Nervous System (CNS) Therapeutic Product
Table 68. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Biogen Company Details
Table 71. Biogen Business Overview
Table 72. Biogen Central Nervous System (CNS) Therapeutic Product
Table 73. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 74. Biogen Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product
Table 78. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Central Nervous System (CNS) Therapeutic Product
Table 83. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 84. Eli Lilly Recent Development
Table 85. Otsuka America Pharmaceutical Company Details
Table 86. Otsuka America Pharmaceutical Business Overview
Table 87. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product
Table 88. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 89. Otsuka America Pharmaceutical Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Central Nervous System (CNS) Therapeutic Product
Table 93. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 94. Merck Recent Development
Table 95. Astrazeneca Company Details
Table 96. Astrazeneca Business Overview
Table 97. Astrazeneca Central Nervous System (CNS) Therapeutic Product
Table 98. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Astrazeneca Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. Teva Pharmaceutical Industries Company Details
Table 105. Teva Pharmaceutical Industries Business Overview
Table 106. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product
Table 107. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 108. Teva Pharmaceutical Industries Recent Development
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Central Nervous System (CNS) Therapeutic Product
Table 112. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2016-2021) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Neurovascular Features
Figure 3. Trauma Features
Figure 4. Mental Health Features
Figure 5. Degenerative Disorder Features
Figure 6. Infections Features
Figure 7. Cancer Features
Figure 8. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2020 VS 2027
Figure 9. Clinical Application Case Studies
Figure 10. Others Case Studies
Figure 11. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 12. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Central Nervous System (CNS) Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2020
Figure 17. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2020
Figure 19. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Central Nervous System (CNS) Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Central Nervous System (CNS) Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Central Nervous System (CNS) Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Central Nervous System (CNS) Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Region (2016-2027)
Figure 41. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Central Nervous System (CNS) Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Central Nervous System (CNS) Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 64. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 66. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 68. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 69. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. Market Analysis and Insights: Global Central Nervous System Therapeutic Market The global Central Nervous System Therapeut…- 世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年） Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics Market Analysis and Insights: Global Central Nervous System Disorders …
- 世界の中枢神経系（CNS）治療市場規模・現状・予測（2021年-2027年） The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. Market Analysis and Insights: Global Central Nervous System Treatment Market The global Central Nervous System Treatment m…
- 世界の中枢神経系（CNS）バイオマーカー市場規模・現状・予測（2021年-2027年） With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease,…
- 世界の色素沈着障害治療市場規模・現状・予測（2021年-2027年） Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are availabl…